# Commission Implementing Regulation (EU) 2020/43 of 17 January 2020 amending Regulation (EU) No 37/2010 to classify the substance ciclesonide as regards its maximum residue limit (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:
Pharmacologically active Substance
Marker residue
Animal Species
MRLs
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Ciclesonide
The sum of ciclesonide and desisobutyryl-ciclesonide, measured as desisobutyryl-ciclesonide after hydrolysis of ciclesonide to desisobutyryl-ciclesonide
Equidae
0,6 μg/kg
4 μg/kg
0,6 μg/kg
0,6 μg/kg
Muscle
Fat
Liver
Kidney
Not for use in animals from which milk is produced for human consumption
Corticoides/Glucocorticoides’

---
Source: https://www.legislation.gov.uk/eur/2020/43/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-43/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.